Swiss venture capital firm Vi Partners has announced the first closing of its latest fund, which is targeting $189 Million to invest in promising technology and healthcare startups. This significant milestone coincides with the firm's 25th anniversary, reinforcing its long-standing commitment to fostering innovation within Switzerland and across Europe. The new fund received strong backing from existing limited partners, signaling continued confidence in the firm's strategic direction and proven track record.
A New Chapter on a 25-Year Legacy
Celebrating a quarter-century of continuous venture activity, Vi Partners has established itself as a cornerstone of the Swiss innovation ecosystem since its founding in 2001. The firm has consistently supported generations of entrepreneurs, contributing to the nation's growth as a leading hub for technological and medical advancements. This new fund represents the next phase of its investment activity, built upon a foundation of deep sector expertise and successful partnerships.
Strategic Focus on Technology and Healthcare
The fund will concentrate on Series A and early-stage investments, continuing a disciplined strategy that has yielded a strong portfolio. In the technology sector, Vi Partners will back companies building mission-critical software and data-driven platforms across enterprise, AI, fintech, and industrial applications. This focus is exemplified by past investments in category leaders like Nexthink and SumUp, showcasing their ability to identify transformative companies.
Within healthcare, the firm will support companies addressing material clinical and systemic needs in biotech, medtech, and digital health. This strategy builds on its experience as an early partner to groundbreaking companies such as AMAL Therapeutics, Kuros Biosciences, and Oculis. By targeting these critical areas, Vi Partners aims to advance solutions that have a tangible impact on patient outcomes and healthcare efficiency.
Leadership's Vision for Collaborative Growth
Managing Partner Diego Braguglia highlighted the firm's consistent focus on supporting teams with strong scientific and technological foundations. He affirmed that this new fund allows for the continuation of a disciplined, long-term investment approach grounded in close collaboration with entrepreneurs. This philosophy ensures that portfolio companies receive not just capital but also strategic guidance to achieve their ambitious goals.
Echoing this sentiment, Managing Partner Olivier Laplace stated that the fund launches a new phase of investment activity for the firm. He emphasized their role as a committed, hands-on partner from the earliest stages, combining capital with invaluable experience, network access, and long-term support. This comprehensive approach is designed to empower founders to build category-defining companies that can compete on a global scale.
Leveraging Switzerland's Thriving Innovation Ecosystem
The announcement comes as Switzerland solidifies its position as one of Europe's premier innovation hubs, driven by world-class academic institutions like ETH Zurich and EPFL. Managing Partner Gaetano Zanon noted the country's particular strengths in life sciences and AI-driven technologies. Vi Partners' deep roots and long-standing presence in this dynamic ecosystem provide a distinct advantage in identifying and nurturing high-potential startups.
With capital deployment from the new fund already underway, Vi Partners is actively seeking to partner with the next generation of innovators. The firm expects to hold subsequent closings throughout the year, further strengthening its capacity to fuel growth in the European tech and healthcare sectors. This latest fund reaffirms Vi Partners' pivotal role in transforming groundbreaking ideas into successful, market-leading enterprises for years to come.